Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

NCT01441947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cabozantinib
DRUG: Fulvestrant

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]